Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Valuing the economic benefits of complex interventions: when maximising health is not sufficient.

Health economics - 1 Mar 2013

Payne Katherine, McAllister Marion, Davies Linda M

Abstract excerpt

Complex interventions, involving interlinked packages of care, challenge the application of current methods of economic evaluation that focus on measuring only health gain. Complex interventions may be problematic on two levels. The complexity means the intervention may not fit into one of the current appraisal systems, and/or maximising health is not the only objective. This paper discusses the implications of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Health Policy

Share to Quality-Adjusted Life Years

Share to United Kingdom

Source

Identifiers

PMID: 22308053
DOI: 10.1002/hec.2795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Valuing the economic benefits of complex interventions: when maximising health is not sufficient.PMID 22308053Read ↗

Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.Semantic proximity Read ↗

Patient reported outcomes and patient empowerment in clinical genetics servicesSemantic proximity Read ↗

Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy TherapiesSemantic proximity Read ↗

Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitableSemantic proximity Read ↗

Patient empowerment in clinical genetics services.Semantic proximity Read ↗

The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?Semantic proximity Read ↗

Health Technology Assessment of Diagnostic Tests: A state of the art review of methods guidance from international organisationsSemantic proximity Read ↗

Genetic risks and healthy choices: creating citizen-consumers of genetic services through empowerment and facilitation.Semantic proximity Read ↗

A Formal Additive Value Model for General Practitioner Compensation: Integrating Functional, Social, and Psychological DimensionsSemantic proximity Read ↗

Biomedical and Healthtech Innovation: The Dilemma Between Purpose, Current Stakeholder Economics, and “Patient” Benefits / Desires — What Might the Future of Health Look Like?Semantic proximity Read ↗

Two-year follow-up of a clustered randomised controlled trial of a multicomponent general practice intervention for people at risk of poor health outcomesSemantic proximity Read ↗

Better and fulfilling healthcare at lower costs: The need to manage health systems as complex adaptive systemsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.